|
1
|
Scott DL, Wolfe F and Huizinga TW:
Rheumatoid arthritis. Lancet. 376:1094–1108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Felson DT, Anderson JJ, Boers M,
Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus
H, Strand V, et al: American college of Rheumatology. Preliminary
definition of improvement in rheumatoid arthritis. Arthritis Rheum.
38:727–735. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeng XF, Zhu SL, Tan AC and Xie XP:
Disease burden and quality of life of rheumatoid arthritis in
China: A systematic review. Chin J Evidence-Based Med. 13:300–307.
2013.
|
|
4
|
Feldmann M and Maini SR: Role of cytokines
in rheumatoid arthritis: An education in pathophysiology and
therapeutics. Immunol Rev. 223:7–19. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Firestein GS: Invasive fibroblast-like
synoviocytes in rheumatoid arthritis. Passive responders or
transformed aggressors? Arthritis Rheum. 39:1781–1790. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartok B and Firestein GS: Fibroblast-like
synoviocytes: Key effector cells in rheumatoid arthritis. Immunol
Rev. 233:233–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Noss EH and Brenner MB: The role and
therapeutic implications of fibroblast-like synoviocytes in
inflammation and cartilage erosion in rheumatoid arthritis. Immunol
Rev. 223:252–270. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abdul-Maksoud RS, Sediq AM, Kattaia A,
Elsayed W, Ezzeldin N, Abdel Galil SM and Ibrahem RA: Serum miR-210
and miR-155 expression levels as novel biomarkers for rheumatoid
arthritis diagnosis. Br J Biomed Sci. 74:209–213. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mookherjee N and El-Gabalawy HS: High
degree of correlation between whole blood and PBMC expression
levels of miR-155 and miR-146a in healthy controls and rheumatoid
arthritis patients. J Immunol Methods. 400-401:106–110. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rajasekhar M, Olsson AM, Steel KJ,
Georgouli M, Ranasinghe U, Brender Read C, Frederiksen KS and Taams
LS: MicroRNA-155 contributes to enhanced resistance to apoptosis in
monocytes from patients with rheumatoid arthritis. J Autoimmun.
79:53–62. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spoerl D, Duroux-Richard I, Louis-Plence P
and Jorgensen C: The role of miR-155 in regulatory T cells and
rheumatoid arthritis. Clin Immunol. 148:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leah E: Rheumatoid arthritis: miR-155
mediates inflammation. Nat Rev Rheumatol. 7:4372011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
La Vaque TJ and Rossiter T: The ethical
use of placebo controls in clinical research: The Declaration of
Helsinki. Appl Psychophysiol Biofeedback. 2623–37. (61-65)2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang W, Chen L, Jiang Y and Shen Y:
miR-26a-5p regulates synovial fibroblast invasion in patients with
rheumatoid arthritis by targeting Smad 1. Med Sci Monit.
24:5178–5184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Y, Qian K, Li C, Ma Y and Chen X:
Roles of microRNA-539 and osteopontin in rheumatoid arthritis. Exp
Ther Med. 15:2681–2687. 2018.PubMed/NCBI
|
|
16
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tavasolian F, Abdollahi E, Rezaei R,
Momtazi-Borojeni AA, Henrotin Y and Sahebkar A: Altered expression
of MicroRNAs in rheumatoid arthritis. J Cell Biochem. 119:478–487.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Murata K, Yoshitomi H, Tanida S, Ishikawa
M, Nishitani K, Ito H and Nakamura T: Plasma and synovial fluid
microRNAs as potential biomarkers of rheumatoid arthritis and
osteoarthritis. Arthritis Res Ther. 12:R862010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akhtar N, Singh AK and Ahmed S:
MicroRNA-17 suppresses TNF-α signaling by interfering with TRAF2
and cIAP2 association in rheumatoid arthritis synovial fibroblasts.
J Immunol. 197:2219–2228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Fei D, Xing J and Du J:
MicroRNA-29a inhibits proliferation and induces apoptosis in
rheumatoid arthritis fibroblast-like synoviocytes by repressing
STAT3. Biomed Pharmacother. 96:173–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li XF, Shen WW, Sun YY, Li WX, Sun ZH, Liu
YH, Zhang L, Huang C, Meng XM and Li J: MicroRNA-20a negatively
regulates expression of NLRP3-inflammasome by targeting TXNIP in
adjuvant-induced arthritis fibroblast-like synoviocytes. Joint Bone
Spine. 83:695–700. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H, Guan SB, Lu Y and Wang F: MiR-140-5p
inhibits synovial fibroblasts proliferation and inflammatory
cytokines secretion through targeting TLR4. Biomed Pharmacother.
96:208–214. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Innala L, Sjöberg C, Möller B, Ljung L,
Smedby T, Södergren A, Magnusson S, Rantapää-Dahlqvist S and
Wallberg-Jonsson S: Co-morbidity in patients with early rheumatoid
arthritis-inflammation matters. Arthritis Res Ther. 18:332016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sharma AR, Sharma G, Lee SS and
Chakraborty C: miRNA-regulated key components of cytokine signaling
pathways and inflammation in rheumatoid arthritis. Med Res Rev.
36:425–439. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ritchie W, Rasko JE and Flamant S:
MicroRNA target prediction and validation. Adv Exp Med Biol.
774:39–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim S, Lee E, Jung J, Lee JW, Kim HJ, Kim
J, Yoo HJ, Lee HJ, Chae SY, Jeon SM, et al: microRNA-155 positively
regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast
cancer. Oncogene. 37:2982–2991. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kong W, He L, Coppola M, Guo J, Esposito
NN, Coppola D and Cheng JQ: MicroRNA-155 regulates cell survival,
growth and chemosensitivity by targeting FOXO3a in breast cancer. J
Biol Chem. 291:228552016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ling N, Gu J, Lei Z, Li M, Zhao J, Zhang
HT and Li X: microRNA-155 regulates cell proliferation and invasion
by targeting FOXO3a in glioma. Oncol Rep. 30:2111–2118. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Q, Li C, Zhu Z, Teng Y, Che X, Wang
Y, Ma Y, Wang Y, Zheng H, Liu Y and Qu X: miR-155-5p antagonizes
the apoptotic effect of bufalin in triple-negative breast cancer
cells. Anticancer Drugs. 27:9–16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Min M, Peng L, Yang Y, Guo M, Wang W and
Sun G: MicroRNA-155 is involved in the pathogenesis of ulcerative
colitis by targeting FOXO3a. Inflamm Bowel Dis. 20:652–659. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Choy EH and Panayi GS: Cytokine pathways
and joint inflammation in rheumatoid arthritis. N Engl J Med.
344:907–916. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Araki Y and Mimura T: The mechanisms
underlying chronic inflammation in rheumatoid arthritis from the
perspective of the epigenetic landscape. J Immunol Res.
2016:62906822016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qi J, Ye X, Ren G, Kan F, Zhang Y, Guo M,
Zhang Z and Li D: Pharmacological efficacy of anti-IL-1β scFv, Fab
and full-length antibodies in treatment of rheumatoid arthritis.
Mol Immunol. 57:59–65. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ruscitti P, Cipriani P, Cantarini L,
Liakouli V, Vitale A, Carubbi F, Berardicurti O, Galeazzi M,
Valenti M and Giacomelli R: Efficacy of inhibition of IL-1 in
patients with rheumatoid arthritis and type 2 diabetes mellitus:
Two case reports and review of the literature. J Med Case Rep.
9:1232015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yoshida Y and Tanaka T: Interleukin 6 and
rheumatoid arthritis. Biomed Res Int. 2014:6983132014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
van Schouwenburg PA, Rispens T and Wolbink
GJ: Immunogenicity of anti-TNF biologic therapies for rheumatoid
arthritis. Nat Rev Rheumatol. 9:164–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miyabe Y, Miyabe C, Iwai Y, Yokoyama W,
Sekine C, Sugimoto K, Harigai M, Miyasaka M, Miyasaka N and Nanki
T: Activation of fibroblast-like synoviocytes derived from
rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic
acid receptor 1 cascade. Arthritis Res Ther. 16:4612014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Garcia-Carbonell R, Divakaruni AS, Lodi A,
Vicente-Suarez I, Saha A, Cheroutre H, Boss GR, Tiziani S, Murphy
AN and Guma M: Critical role of glucose metabolism in rheumatoid
arthritis fibroblast-like Synoviocytes. Arthritis Rheumatol.
68:1614–1626. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Calnan DR and Brunet A: The FoxO code.
Oncogene. 27:2276–2288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Qian Z, Ren L, Wu D, Yang X, Zhou Z, Nie
Q, Jiang G, Xue S, Weng W, Qiu Y and Lin Y: Overexpression of
FoxO3a is associated with glioblastoma progression and predicts
poor patient prognosis. Int J Cancer. 140:2792–2804. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nho RS, Hergert P, Kahm J, Jessurun J and
Henke C: Pathological alteration of FoxO3a activity promotes
idiopathic pulmonary fibrosis fibroblast proliferation on type i
collagen matrix. Am J Pathol. 179:2420–2430. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Czyszek JA, Milkiewicz M, Elias E and
Milkiewicz PJG: Proapoptotic protein bim and its upstream activator
Foxo3A are overexpressed in primary biliary cirrhosis but not in
primary sclerosing cholangitis. Gut. 60 (Suppl 1):A2272011.
View Article : Google Scholar
|
|
43
|
Harada Y, Harada Y, Elly C, Ying G, Paik
JH, DePinho RA and Liu YC: Transcription factors Foxo3a and Foxo1
couple the E3 ligase Cbl-b to the induction of Foxp3 expression in
induced regulatory T cells. J Exp Med. 207:1381–1391. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lin L, Hron JD and Peng SL: Regulation of
NF-kappaB, Th activation, and autoinflammation by the forkhead
transcription factor Foxo3a. Immunity. 21:203–213. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu
C, Li J, Wang X and Song L: Unregulated miR-96 induces cell
proliferation in human breast cancer by downregulating
transcriptional factor FOXO3a. PLoS One. 5:e157972010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu Y, Peng H, Cui M, Whitney NP, Huang Y
and Zheng JC: CXCL12 increases human neural progenitor cell
proliferation through Akt-1/FOXO3a signaling pathway. J Neurochem.
109:1157–1167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nakao T, Geddis AE, Fox NE and Kaushansky
K: PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced
proliferation of primary megakaryocytes in vitro and in vivo via
modulation of p27(Kip1). Cell Cycle. 7:257–266. 2008. View Article : Google Scholar : PubMed/NCBI
|
